MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Experiencing Life with Tourette Syndrome: The Invisible Effects of Tics

    J. Martindale, J. Carson, K. Reilly, K. Pring, L. Chapman, J. Salsman, S. Daniel, S. Rapp, R. Strowd, E. Storch, J. Mink (Winston Salem, USA)

    Objective: To evaluate how individuals with Tourette Syndrome experience stigma. Background: Persistent Tic Disorders (PTD), including Tourette Syndrome (TS), are neurodevelopmental disabilities characterized by multiple…
  • 2024 International Congress

    Safety and Efficacy of Vatiquinone Treatment in Friedreich Ataxia Patients from MOVE-FA: a Phase 3, Double-blind, Placebo-controlled Trial

    D. Lynch, A. Duquette, M. França Jr, S. Perlman, A. Durr, E. Bertini, A. Darling, K. Mathews, L. Schöls, A. Fournier, M. Delatycki, S. Subramony, R. Roxburgh, O. Zhang, C. Rummey, A. Salvucci, B. Yao, J. Cherry, L. Golden, T. Zesiewicz (Philadelphia, USA)

    Objective: Describe the results of vatiquinone from MOVE-FA (NCT04577352), the 72-week placebo-controlled phase 3 study of patients with Friedreich Ataxia (FA). Background: FA, the most…
  • 2024 International Congress

    Nocturnal Use of Add-On Medications for Parkinson’s Disease: Post Hoc Analysis of the COSMOS Study

    T. Gurevich, S. O'Sullivan, J. Parra, M. O'Meara, J. Zamudio, A. Fasano (Tel Aviv-Yafo, Israel)

    Objective: To assess nighttime use of add-on medications for Parkinson’s disease (PD) in a post hoc analysis of the COSMOS (COmedication Study assessing Mono- and…
  • 2024 International Congress

    Subgroup Analyses of a Phase 3 Randomized Study of Levodopa/Carbidopa Infusion (ND0612) for Parkinson’s Patients

    W. Poewe, A. Espay, N. Lopes, J. Ferreira (Innsbruck, Austria)

    Objective: Evaluate efficacy and safety outcomes for different patient subgroups categorized according to their baseline characteristics from a Phase 3 study of ND0612. Background: Primary…
  • 2024 International Congress

    REGENERATE-PD: A Phase 2, Randomized, Double-Blind, Surgery-Controlled Study of GDNF Gene Therapy (AAV2-GDNF; AB-1005) for Moderate Stage Parkinson’s Disease

    A. Whone, C. Christine, M. Luz, R. Richardson, C. Urrea, N. Chhabria, C. Letourneau, M. Wisniewski, M. Fiandaca, A. van Laar, A. Kells, K. Bankiewicz (Bristol, United Kingdom)

    Objective: To present the REGENERATE-PD study design: a phase 2, randomized, double-blind, surgery-controlled trial assessing efficacy and safety of intraputaminal adeno-associated virus serotype 2 containing…
  • 2024 International Congress

    AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease

    SB. Soumma, D. Peterson, H. Ghasemzadeh, S. Mehta (Tempe, USA)

    Objective: This study developed a novel patient-independent, cost-effective AI model for detecting Freezing of Gait (FoG), using a single wearable sensor and without the need…
  • 2024 International Congress

    A Randomized, Double-Blind, Placebo-Controlled Trial of a Multi-Strain Probiotic for Anxiety in Parkinson’s Disease

    J. Lam, P. Uzelman, J. Zhu, D. Meng, F. Pio, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the effect of a multi-strain probiotic on anxiety in patients with Parkinson’s disease (PD). Background: There is a lack of dedicated randomized…
  • 2024 International Congress

    Comparing Ring and Directional Globus Pallidus Stimulation Effects on Parkinson’s Gait

    A. Ragothaman, Z. Nhem, G. Harker, P. Carlson-Kuhta, L. Neilson, C. Zarns, M. Case, A. Becker, R. Raike, K. Burchiel, M. Mancini, D. Safarpour (Portland, USA)

    Objective: This study aims to assess the possible benefits of directional stimulation for motor symptoms in Parkinson’s disease (PD) by comparing therapeutic directional versus ring…
  • 2024 International Congress

    A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson’s Disease (PADOVA): Rationale, Design, and Baseline Data

    T. Nikolcheva, G. Pagano, N. Pross, T. Simuni, K. Marek, R. Postuma, N. Pavese, F. Stocchi, K. Seppi, G. Respondek, A. Monnet, N. Shariati, L. Rutten-Jacobs, T. Kustermann, K. Taylor, D. Trundell, H. Svoboda, A. Bonni, P. Fontoura, R. Doody (Basel, Switzerland)

    Objective: To evaluate the effect on slowing motor progression and the safety of prasinezumab, a humanized monoclonal antibody targeting aggregated alpha-synuclein, in individuals with early…
  • 2024 International Congress

    Distinct pattern of synaptic loss in Parkinson’s disease depression and initial findings from the Yale Ketamine PD (KET-PD) trial

    M. Ansari, Y. Yang, S. Elliott, M. Naganawa, P. Honhar, M. Dias, S. Henry, J. Ropchan, R. Comley, N. Nabulsi, Y. Huang, R. Carson, S. Finnema, S. Nikayin, S. Tinaz, D. Matuskey, G. Sanacora, S. Holmes (New Haven, USA)

    Objective: To investigate synaptic loss in Parkinson's Disease depression (PDd) using PET and [11C]UCB-J (a marker for synaptic density) and present the initial blinded findings…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley